177 related articles for article (PubMed ID: 19763940)
1. Cleavage of plasmid DNA by eukaryotic topoisomerase II.
Bandele OJ; Osheroff N
Methods Mol Biol; 2009; 582():39-47. PubMed ID: 19763940
[TBL] [Abstract][Full Text] [Related]
2. Bimodal recognition of DNA geometry by human topoisomerase II alpha: preferential relaxation of positively supercoiled DNA requires elements in the C-terminal domain.
McClendon AK; Gentry AC; Dickey JS; Brinch M; Bendsen S; Andersen AH; Osheroff N
Biochemistry; 2008 Dec; 47(50):13169-78. PubMed ID: 19053267
[TBL] [Abstract][Full Text] [Related]
3. Catalytic core of human topoisomerase IIα: insights into enzyme-DNA interactions and drug mechanism.
Lindsey RH; Pendleton M; Ashley RE; Mercer SL; Deweese JE; Osheroff N
Biochemistry; 2014 Oct; 53(41):6595-602. PubMed ID: 25280269
[TBL] [Abstract][Full Text] [Related]
4. Impact of the C-terminal domain of topoisomerase IIalpha on the DNA cleavage activity of the human enzyme.
Dickey JS; Osheroff N
Biochemistry; 2005 Aug; 44(34):11546-54. PubMed ID: 16114891
[TBL] [Abstract][Full Text] [Related]
5. Human topoisomerase IIalpha rapidly relaxes positively supercoiled DNA: implications for enzyme action ahead of replication forks.
McClendon AK; Rodriguez AC; Osheroff N
J Biol Chem; 2005 Nov; 280(47):39337-45. PubMed ID: 16188892
[TBL] [Abstract][Full Text] [Related]
6. Mutation of cysteine residue 455 to alanine in human topoisomerase IIalpha confers hypersensitivity to quinones: enhancing DNA scission by closing the N-terminal protein gate.
Bender RP; Osheroff N
Chem Res Toxicol; 2007 Jun; 20(6):975-81. PubMed ID: 17516663
[TBL] [Abstract][Full Text] [Related]
7. The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs.
McClendon AK; Osheroff N
Biochemistry; 2006 Mar; 45(9):3040-50. PubMed ID: 16503659
[TBL] [Abstract][Full Text] [Related]
8. Topoisomerase Assays.
Nitiss JL; Kiianitsa K; Sun Y; Nitiss KC; Maizels N
Curr Protoc; 2021 Oct; 1(10):e250. PubMed ID: 34606690
[TBL] [Abstract][Full Text] [Related]
9. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
Marx G; Zhou H; Graves DE; Osheroff N
Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
[TBL] [Abstract][Full Text] [Related]
10. Exocyclic DNA lesions stimulate DNA cleavage mediated by human topoisomerase II alpha in vitro and in cultured cells.
Vélez-Cruz R; Riggins JN; Daniels JS; Cai H; Guengerich FP; Marnett LJ; Osheroff N
Biochemistry; 2005 Mar; 44(10):3972-81. PubMed ID: 15751973
[TBL] [Abstract][Full Text] [Related]
11. A high-throughput-compatible, fluorescence anisotropy-based assay for ATP-dependent supercoiled DNA relaxation by human topoisomerase IIα.
Shapiro AB
Biochem Pharmacol; 2013 May; 85(9):1269-77. PubMed ID: 23415903
[TBL] [Abstract][Full Text] [Related]
12. Coordinating the two protomer active sites of human topoisomerase IIalpha: nicks as topoisomerase II poisons.
Deweese JE; Osheroff N
Biochemistry; 2009 Feb; 48(7):1439-41. PubMed ID: 19166355
[TBL] [Abstract][Full Text] [Related]
13. Interaction in vitro of type III intermediate filament proteins with supercoiled plasmid DNA and modulation of eukaryotic DNA topoisomerase I and II activities.
Li G; Tolstonog GV; Sabasch M; Traub P
DNA Cell Biol; 2002 Oct; 21(10):743-69. PubMed ID: 12443544
[TBL] [Abstract][Full Text] [Related]
14. Site-specific DNA cleavage by Chlorella virus topoisomerase II.
Fortune JM; Dickey JS; Lavrukhin OV; Van Etten JL; Lloyd RS; Osheroff N
Biochemistry; 2002 Oct; 41(39):11761-9. PubMed ID: 12269818
[TBL] [Abstract][Full Text] [Related]
15. Contributions of the D-Ring to the activity of etoposide against human topoisomerase IIα: potential interactions with DNA in the ternary enzyme--drug--DNA complex.
Pitts SL; Jablonksy MJ; Duca M; Dauzonne D; Monneret C; Arimondo PB; Anklin C; Graves DE; Osheroff N
Biochemistry; 2011 Jun; 50(22):5058-66. PubMed ID: 21548574
[TBL] [Abstract][Full Text] [Related]
16. Structural determinants of the catalytic inhibition of human topoisomerase IIα by salicylate analogs and salicylate-based drugs.
Bau JT; Kurz EU
Biochem Pharmacol; 2014 Jun; 89(4):464-76. PubMed ID: 24695359
[TBL] [Abstract][Full Text] [Related]
17. Metal ion interactions in the DNA cleavage/ligation active site of human topoisomerase IIalpha.
Deweese JE; Guengerich FP; Burgin AB; Osheroff N
Biochemistry; 2009 Sep; 48(38):8940-7. PubMed ID: 19697956
[TBL] [Abstract][Full Text] [Related]
18. Stimulated activity of human topoisomerases IIalpha and IIbeta on RNA-containing substrates.
Wang Y; Knudsen BR; Bjergbaek L; Westergaard O; Andersen AH
J Biol Chem; 1999 Aug; 274(32):22839-46. PubMed ID: 10428869
[TBL] [Abstract][Full Text] [Related]
19. Topoisomerase II-mediated cleavage of plasmid DNA.
Burden DA; Froelich-Ammon SJ; Osheroff N
Methods Mol Biol; 2001; 95():283-9. PubMed ID: 11089240
[No Abstract] [Full Text] [Related]
20. Novel trifluoromethylated 9-amino-3,4-dihydroacridin-1(2H)-ones act as covalent poisons of human topoisomerase IIα.
Infante Lara L; Sledge A; Laradji A; Okoro CO; Osheroff N
Bioorg Med Chem Lett; 2017 Feb; 27(3):586-589. PubMed ID: 27998679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]